Type to search

China Power Crisis May Hit Indian Pharma Sector: BS

The power crisis in China may disrupt the Indian pharmaceuticals market, as prices of ‘active’ ingredients have shot up recently because of supply chain problems.

A person walks near a China Energy coal-fired power plant in Shenyang, Liaoning province, China September 29, 2021. REUTERS/Tingshu Wang


The power crisis in China may disrupt the Indian pharmaceuticals market if it persists, Business Standard reported on Thursday, quoting people in the domestic industry.

Prices of active pharmaceutical ingredients (APIs), or raw materials used to make drugs that are mostly imported from China, have gone through the roof amid delays in shipments, data showed. Indian pharma companies import 66-70% of their bulk drug requirements from China, the report said.

The prices of Penicillin-G from China have gone up from $14 per unit to $26 in just one month, the report said, quoting Sudarshan Jain, secretary general of the Indian Pharmaceutical Alliance (IPA), a lobby for big pharma firms in India.

Read the full report: Business Standard.




China Power Generators’ Profits Tumble On Record Coal Prices

China Power Generators Told to Stockpile Coal to Avert More Blackouts

Explainer: Why Is There A Power Crisis In China?



Jim Pollard

Jim Pollard is an Australian journalist based in Thailand since 1999. He worked for News Ltd papers in Sydney, Perth, London and Melbourne before travelling through SE Asia in the late 90s. He was a senior editor at The Nation for 17+ years and has a family in Bangkok.


AF China Bond